Please login to the form below
Good news for AZ on gout candidate lesinurad
Phase III trial backs planned filing in 2014
Roche signs Parkinson's deal with Prothena
Antibody development agreement is worth up to $600m
CAHG and Diaceutics launch new consultancy
Bioceutics will provide marketing and education consultancy specific to personalised healthcare
First Cymbalta generics approved in the US
Lilly prepares for onslaught of competition for antidepressant
GSK invests £200m in UK medicine manufacturing
Will upgrade two sites and build centre for manufacturing innovation
G8 sets 2025 target for effective dementia treatment
World leaders pledge more research funding
Merck takes Alzheimer's hope into phase III
MK-8931 moves to late-stage study after positive early data
Publicis Groupe spending spree continues
Marketing firm buys US-based healthcare analytics firm Verilogue
Digital blooms: multichannel marketing in China
The evolution of marketing and its increasing use of new channels is as relevant to China as it is to mature pharma markets
-
This month in 1901: The first Nobel Prize awardsSerum therapy work took inaugural medicine award
-
Smart Glasses: A new look for healthcare?Wearable computer devices like Google Glass are tipped to become the next big technology trend, and have exciting health applications
-
Police to probe Novo Nordisk over disclosure delayRegulator says pharma company was late to announce FDA decision to not approve Tresiba and Ryzodeg
-
EC fines J&J and Novartis in pay-for-delay caseSays companies delayed entry of generic painkiller
-
IMI launches dementia trials allianceEU group wants to revamp approach to Alzheimer’s research
-
FDA panel backs Takeda's inflammatory bowel disease drugVedolizumab on course for US approval to treat Crohn’s disease and ulcerative colitis
-
Sanofi's Aubagio backed by NICEOral MS drug recommended for NHS use in England and Wales
-
Novartis' Tasigna tops Glivec in long-term trialBoost ahead of patent expiry for leukaemia drug
-
AZ donates Brixham lab to Plymouth UniversityWill create global research and education facility
Latest appointments
-
BMS appoints leading oncologist to boardThomas Lynch is director of Yale Cancer Center
-
Senior hire for 3D CommunicationsAllison May Rosen joins as communications lead for FDA Advisory Committee projects
-
ABPI names NHS partnership managerRaj Tugnet will lead work to strengthen pharma/NHS collaboration in UK
-
Senior hires at Precision Health MediaNew VP for ad sales, chief financial officer ad member of the board
-
Ketchum loses healthcare headAmanda Sefton leaves to pursue “passion project” in wine trade
Featured jobs
- Global Brand Manager
- flexible salary + bonus + car allowance + benefits
- Brand Director - Highly Specialised Product - Global remit
- Highly Competitive Basic, Bonus + Benefits
- Commercial Manager
- Negotiable
- Regulatory Affairs Senior Manager, CMC - 12 month cotnract
- Competitive
Subscribe to our email news alerts
- Empowered patients: Heeding patient behaviours key to successful multi-channel pharma marketing
- J&J extends partnering network in UK
- Good news for AZ on gout candidate lesinurad
- WebMD to debut quantified self venture in 2014
- Roche signs Parkinson's deal with Prothena
- BMS appoints leading oncologist to board
PMHub
Biocair
THE specialist courier to the Biotechnology, Pharmaceutical and Scientific Research Industries....
Latest intelligence
- Pharma deals during November 2013
- Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month...
- Deal Watch table for November 2013
- Table listing all the major pharma mergers, acquisitions and collaborations in the past month...
- Emerging Markets: The Second Tier
- eyeforpharma has spoken to innovative industry experts and offers you this exclusive guide to ensure permanence and sustainability in some of the fastest growing markets in the world....
Quick links
